Provided by Tiger Fintech (Singapore) Pte. Ltd.

Royalty Pharma plc

36.37
+0.18000.50%
Post-market: 36.23-0.1400-0.38%16:20 EDT
Volume:1.19M
Turnover:43.14M
Market Cap:15.33B
PE:14.83
High:36.43
Open:36.14
Low:35.96
Close:36.19
Loading ...

Citi Sticks to Their Buy Rating for Royalty Pharma (RPRX)

TIPRANKS
·
25 Jun

Revolution Medicines Shares Down 3.5% After Deal With Royalty Pharma

THOMSON REUTERS
·
24 Jun

BRIEF-Royalty Pharma And Revolution Medicines Enter Into Funding Agreements For Up To $2 Billion

Reuters
·
24 Jun

Royalty Pharma Plc - to Provide up to $1.25 Bln in Exchange for a Synthetic Royalty on Annual Worldwide Net Sales of Daraxonrasib

THOMSON REUTERS
·
24 Jun

Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for up to $2 Billion

THOMSON REUTERS
·
24 Jun

Citi Keeps Their Buy Rating on Royalty Pharma (RPRX)

TIPRANKS
·
17 Jun

Royalty Pharma Enters into Amended Loan Agreement with Bank of America, Adding RPH and RP LLC as Borrowers

Reuters
·
20 May

Royalty Pharma Closes Acquisition of External Manager

MT Newswires Live
·
17 May

BRIEF-Royalty Pharma Completes The Acquisition Of Its External Manager

Reuters
·
17 May

Royalty Pharma Completes Acquisition of RP Management, Internalizes Operations

Reuters
·
17 May

Royalty Pharma Completes the Acquisition of Its External Manager

THOMSON REUTERS
·
17 May

Royalty Pharma : Morgan Stanley Resumes Coverage With Overweight Rating; Target Price $51

THOMSON REUTERS
·
16 May

Royalty Pharma plc to Participate in BofA Securities 2025 Healthcare Conference

Reuters
·
13 May

Royalty Pharma Shareholders Approve External Manager Acquisition

MT Newswires Live
·
13 May

Royalty Pharma Shareholders Approve Manager Internalization with 99.9% Support, Unlocking Significant Cash Savings

Reuters
·
13 May

Royalty Pharma Announces Shareholder Approval of Its External Manager Acquisition

THOMSON REUTERS
·
13 May

Press Release: Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition

Dow Jones
·
13 May

Royalty Pharma plc Conducted Annual and Special Shareholders' Meeting

Reuters
·
13 May

Royalty Pharma PLC reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Royalty Pharma Q1 Net Income Rises, Revenue Unchanged

MT Newswires Live
·
08 May